Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder

被引:156
作者
Denys, D [1 ]
van der Wee, N [1 ]
Janssen, J [1 ]
De Geus, F [1 ]
Westenberg, HGM [1 ]
机构
[1] Univ Utrecht, Med Ctr, Dept Psychiat, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands
关键词
obsessive-compulsive disorder; dopamine; single photon emission computed tomography;
D O I
10.1016/j.biopsych.2004.01.023
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Despite growing evidence for involvement of the dopaminergic system in obsessive-compulsive disorder (OCD), the functional anatomy of the dopaminergic system in the basal ganglia has been investigated sparsely. Methods: Dopamine D-2 receptor binding was assessed in 10 medication-free OCD patients and 10 healthy control subjects, matched forage, gender, and handedness. The binding potential was measured with single photon emission computerized tomography (SPECT) and infusion of the D-2 receptor radiotracer [I-123] iodobenzamide. With magnetic resonance imaging as reference, regions of interest (caudate and putamen) were delineated for each hemisphere and coregistered with the corresponding SPECT scans. Results: Dopamine D-2 receptor binding in the left caudate nucleus was significantly lower in the patients with CCD than in healthy control subjects [F(1, 18) = 7.0, p = .016]. In addition, an interhemispheric difference was observed in the patient sample. Both the D-2 receptor binding potential (df = 9, p = .012), and the volume (df = 9, p = .029) of the left caudate nucleus were statistically significantly reduced relative to the right caudate nucleus. Conclusions: This study provides in vivo evidence for abnormalities in the binding potential of the dopamine D-2 receptor, which suggest the direct involvement of the dopaminergic system in the pathophysiology of OCD.
引用
收藏
页码:1041 / 1045
页数:5
相关论文
共 43 条
  • [1] FUNCTIONAL ARCHITECTURE OF BASAL GANGLIA CIRCUITS - NEURAL SUBSTRATES OF PARALLEL PROCESSING
    ALEXANDER, GE
    CRUTCHER, MD
    [J]. TRENDS IN NEUROSCIENCES, 1990, 13 (07) : 266 - 271
  • [2] DOPAMINE BLOCKING ACTIVITY OF CLOMIPRAMINE IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER
    AUSTIN, LS
    LYDIARD, RB
    BALLENGER, JC
    COHEN, BM
    LARAIA, MT
    ZEALBERG, JJ
    FOSSEY, MD
    ELLINWOOD, EH
    [J]. BIOLOGICAL PSYCHIATRY, 1991, 30 (03) : 225 - 232
  • [3] METHODS AND THEORY OF RELIABILITY
    BARTKO, JJ
    CARPENTER, WT
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1976, 163 (05) : 307 - 317
  • [4] Role of serotonin in obsessive-compulsive disorder
    Baumgarten, HG
    Grozdanovic, Z
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 : 13 - 20
  • [5] BENKELFAT C, 1990, ARCH GEN PSYCHIAT, V47, P840
  • [6] PLASMA-CATECHOLAMINES AND THEIR METABOLITES IN OBSESSIVE-COMPULSIVE DISORDER
    BENKELFAT, C
    MEFFORD, IN
    MASTERS, CF
    NORDAHL, TE
    KING, AC
    COHEN, RM
    MURPHY, DL
    [J]. PSYCHIATRY RESEARCH, 1991, 37 (03) : 321 - 331
  • [7] Dopamine function in obsessive-compulsive disorder: Growth hormone response to apomorphine stimulation
    Brambilla, F
    Bellodi, L
    Perna, G
    Arancio, C
    Bertani, A
    [J]. BIOLOGICAL PSYCHIATRY, 1997, 42 (10) : 889 - 897
  • [8] Treatment of late-onset OCD following basal ganglia infarct
    Carmin, CN
    Wiegartz, PS
    Yunus, U
    Gillock, KL
    [J]. DEPRESSION AND ANXIETY, 2002, 15 (02) : 87 - 90
  • [9] AUTOMATIC 3D INTERSUBJECT REGISTRATION OF MR VOLUMETRIC DATA IN STANDARDIZED TALAIRACH SPACE
    COLLINS, DL
    NEELIN, P
    PETERS, TM
    EVANS, AC
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1994, 18 (02) : 192 - 205
  • [10] Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: An open-label study
    Denys, D
    van Megen, H
    Westenberg, H
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (08) : 700 - 703